These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34823523)

  • 21. Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.
    Lu HC; Chang YS; Chang CC; Lin CH; Chang JG
    J Clin Lab Anal; 2015 May; 29(3):220-5. PubMed ID: 24798984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.
    Liu H; Yang HL; Xu JW; Wang JZ; Nie RH; Li CF
    Malar J; 2013 Nov; 12():409. PubMed ID: 24215565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between CYP2D6 phenotype and recurrence of Plasmodium vivax infection in south Korean patients.
    Choi S; Choi H; Park SY; Kwak YG; Song JE; Shin SY; Baek JH; Shin HI; Cho SH; Lee SE; Kwon JR; Park S; Kim M; Oh HS; Kim YC; Kim MJ; Yeom JS
    Malar J; 2022 Oct; 21(1):289. PubMed ID: 36217154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study on relapse/re-infection rate of Plasmodium vivax malaria and identification of the predominant genotypes of P. vivax in two endemic districts of Nepal.
    Manandhar S; Bhusal CL; Ghimire U; Singh SP; Karmacharya DB; Dixit SM
    Malar J; 2013 Sep; 12():324. PubMed ID: 24041296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.
    Chamchoy K; Sudsumrit S; Thita T; Krudsood S; Patrapuvich R; Boonyuen U
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010986. PubMed ID: 36508454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of CYP2D6 Genetic Variation on Radical Cure of Plasmodium vivax Malaria.
    Suarez-Kurtz G
    Clin Pharmacol Ther; 2021 Sep; 110(3):595-598. PubMed ID: 34042179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
    Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
    Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of climate variability on Plasmodium vivax and Plasmodium falciparum malaria in Yunnan Province, China.
    Bi Y; Yu W; Hu W; Lin H; Guo Y; Zhou XN; Tong S
    Parasit Vectors; 2013 Dec; 6():357. PubMed ID: 24341555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 2D6 profiles and anti-relapse efficacy of tafenoquine against
    Dowd S; Chen N; Gatton ML; Edstein MD; Cheng Q
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0101423. PubMed ID: 37971260
    [No Abstract]   [Full Text] [Related]  

  • 31.
    Salles PF; Perce-da-Silva DS; Rossi AD; Raposo LR; Ramirez Ramirez AD; Pereira Bastos OM; Pratt-Riccio LR; Cassiano GC; Baptista ARS; Cardoso CC; Banic DM; Machado RLD
    Front Pharmacol; 2021; 12():542342. PubMed ID: 34366834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia.
    Golassa L; White MT
    Malar J; 2017 Jul; 16(1):301. PubMed ID: 28750669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed gametocyte clearance in
    Salazar YEAR; Louzada J; Puça MCSdB; Guimarães LFF; Vieira JLF; Siqueira AMd; Gil JP; Brito CFAd; Sousa TNd
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0120423. PubMed ID: 38411047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases.
    de Pina-Costa A; Silvino ACR; Dos Santos EM; Pedro RS; Moreira J; Umana GL; da Silva ADT; da Rosa Santos OHL; de Deus Henriques KM; Daniel-Ribeiro CT; Brasil P; Sousa TN; Siqueira AM
    Malar J; 2021 Aug; 20(1):341. PubMed ID: 34391426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.
    Maneerattanasak S; Gosi P; Krudsood S; Chimma P; Tongshoob J; Mahakunkijcharoen Y; Sukasem C; Imwong M; Snounou G; Khusmith S
    Malar J; 2017 May; 16(1):228. PubMed ID: 28558712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism analysis of propeller domain of k13 gene in Plasmodium ovale curtisi and Plasmodium ovale wallikeri isolates original infection from Myanmar and Africa in Yunnan Province, China.
    Chen M; Dong Y; Deng Y; Xu Y; Liu Y; Zhang C; Huang H
    Malar J; 2020 Jul; 19(1):246. PubMed ID: 32660505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013.
    Liu H; Yang HL; Tang LH; Li XL; Huang F; Wang JZ; Li CF; Wang HY; Nie RH; Guo XR; Lin YX; Li M; Xu JW
    Malar J; 2014 Sep; 13():364. PubMed ID: 25224069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
    Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of CYP2D6 genotypes on Plasmodium vivax recurrence after primaquine treatment: A meta-analysis.
    Park YA; Park KH; Yoon HY; Yee J; Gwak HS
    Travel Med Infect Dis; 2022; 48():102333. PubMed ID: 35452835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.